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Inhibition of PIK3 Signaling Pathway Members by the Ovotoxicant
4-Vinylcyclohexene Diepoxide in Rats
Abstract
4-Vinylcyclohexene diepoxide (VCD), an occupational chemical that specifically destroys primordial and
small primary follicles in the ovaries of rats and mice, is thought to target an oocyte-expressed tyrosine kinase
receptor, Kit. This study compared the temporal effect of VCD on protein distribution of KIT and its
downstream PIK3-activated proteins, AKT and FOXO3. Postnatal Day 4 Fischer 344 rat ovaries were cultured
in control media ± VCD (30 μM) for 2–8 days (d2–d8). KIT, AKT, phosphorylated AKT, FOXO3, and
pFOXO3 protein levels were assessed by Western blotting and/or immunofluorescence staining with confocal
microscopy. Phosphorylated AKT was decreased (P < 0.05) in oocyte nuclei in primordial (39% decrease)
and small primary (37% decrease) follicles within 2 days of VCD exposure. After d4, VCD reduced (P < 0.05)
oocyte staining for KIT (primordial, 44% decrease; small primary, 39% decrease) and FOXO3 (primordial,
40% decrease; small primary, 36% decrease) protein. Total AKT and pFOXO3 were not affected by VCD at
any time. Akt1 mRNA, as measured by quantitative RT-PCR, was reduced (P < 0.05) by 23% on d4 of VCD
exposure, but returned to control levels on d6 and d8. VCD exposure reduced Foxo3amRNA by 26% on d6 (P
< 0.05) and by 23% on d8 (P < 0.1). These results demonstrate that the earliest observed effect of VCD is an
inhibition of phosphorylation and nuclear localization of AKT in the oocyte of primordial and small primary
follicles. This event is followed by reductions in KIT and FOXO3 protein subcellular distribution prior to
changes in mRNA. Thus, these findings further support that VCD induces ovotoxicity by directly targeting
the oocyte through posttranslational inhibition of KIT-mediated signaling components.
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and Patricia B. Hoyer2,5
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ABSTRACT
4-Vinylcyclohexene diepoxide (VCD), an occupational chem-
ical that specifically destroys primordial and small primary
follicles in the ovaries of rats and mice, is thought to target an
oocyte-expressed tyrosine kinase receptor, Kit. This study
compared the temporal effect of VCD on protein distribution
of KIT and its downstream PIK3-activated proteins, AKT and
FOXO3. Postnatal Day 4 Fischer 344 rat ovaries were cultured
in control media 6 VCD (30 lM) for 2–8 days (d2–d8). KIT,
AKT, phosphorylated AKT, FOXO3, and pFOXO3 protein levels
were assessed by Western blotting and/or immunofluorescence
staining with confocal microscopy. Phosphorylated AKT was
decreased (P , 0.05) in oocyte nuclei in primordial (39%
decrease) and small primary (37% decrease) follicles within 2
days of VCD exposure. After d4, VCD reduced (P , 0.05) oocyte
staining for KIT (primordial, 44% decrease; small primary, 39%
decrease) and FOXO3 (primordial, 40% decrease; small
primary, 36% decrease) protein. Total AKT and pFOXO3 were
not affected by VCD at any time. Akt1 mRNA, as measured by
quantitative RT-PCR, was reduced (P , 0.05) by 23% on d4 of
VCD exposure, but returned to control levels on d6 and d8. VCD
exposure reduced Foxo3a mRNA by 26% on d6 (P , 0.05) and
by 23% on d8 (P , 0.1). These results demonstrate that the
earliest observed effect of VCD is an inhibition of phosphory-
lation and nuclear localization of AKT in the oocyte of
primordial and small primary follicles. This event is followed
by reductions in KIT and FOXO3 protein subcellular distribution
prior to changes in mRNA. Thus, these findings further support
that VCD induces ovotoxicity by directly targeting the oocyte
through posttranslational inhibition of KIT-mediated signaling
components.
follicle, ovary, toxicology
INTRODUCTION
KIT is an oocyte-expressed receptor protein tyrosine kinase
[1–3]. The ligand for KIT, KITLG, (also known as Stem Cell
factor, Steel Factor) is expressed in granulosa cells [4]. Ovarian
KITLG/KIT signaling in primordial and small primary follicles
is thought to be essential for oocyte viability and survival in a
developmental stage when functional follicle-stimulating
hormone receptors are not yet expressed [5, 6]. KITLG
stimulation of Postnatal Day (PND) 8 mouse and PND5 rat
oocytes demonstrated increased phosphorylation of AKT
(downstream of phosphatidylinositol-3 kinase; PIK3), which
could be blocked using ACK2, a KIT-neutralizing antibody
[7]. Further, treatment of mouse and rat oocytes with the PIK3
inhibitor LY294002 blocked the phosphorylation of AKT
induced by KITLG [7]. Thus, binding of KITLG to KIT has
been shown to activate the PIK3 signaling pathway. In addition
to oocyte viability, members of the PIK3 signaling pathway
have been demonstrated to play important roles in primordial to
small primary follicle activation and recruitment [6–12].
AKT functions as a central and critical molecule in the PIK3
signaling pathway. Akt1 mRNA is located in oocytes of
primordial and small primary follicles of PND8 and PND12
mouse ovaries, with lower expression in granulosa cells [7]. A
serine residue on AKT, Ser473, must be phosphorylated in order
for it to be fully activated [13]. It has been shown that Ser473
pAKT is highly distributed in the oocyte of rat primordial
follicles, with reduced abundance at the primary follicle stage
[14]. Once activated, pAKT regulates a host of cellular
responses such as cell growth, cell cycle entry, and cell
survival.
A key molecule regulated by AKT is a member of the
forkhead transcription factor family FOXO3 (also known as
FKHR-L1). FOXO3 phosphorylation (pFOXO3) is a down-
stream event in PIK3 signaling. Phosphorylation of FOXO3
followed KITLG stimulation of PND8 mouse oocytes. Further,
this event was prevented by PIK3 inhibition with LY294002
[7]. A role for FOXO3 in regulation of primordial follicle
activation and recruitment was demonstrated by Castrillon et
al. [9]. Female Foxo3-null mice showed an age-dependent
decline in reproductive fitness and were sterile by 15 wk of
age. This presumably resulted from unregulated recruitment of
follicles from the primordial pool. In contrast, oocyte-specific
overexpression of Foxo3 resulted in infertile females as a result
of retarded primordial follicle recruitment [10]. Thus, it appears
that FOXO3 plays a role in determining the rate of primordial
follicle activation/recruitment.
Because the mammalian ovary at birth contains a finite
number of primordial follicles that cannot be regenerated [15],
depletion of this follicle pool can lead to premature ovarian
failure. 4-vinylcyclohexene (VCH) is an occupational chemical
formed by dimerization of 1,3-butadiene and is a by-product of
the pesticide, rubber, plastic, and flame retardant industries
[16]. A metabolite of VCH, 4-vinylcyclohexene diepoxide
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(VCD) is used as an industrial diluent for epoxides [17]. VCD
is ovotoxic and has been shown to selectively destroy small
preantral (primordial and primary) [18–21] follicles in the
ovaries of mice and rats via acceleration of atresia (apoptosis)
[18, 19, 22–24].
A time course of in vitro VCD (30 lM) exposure of
neonatal rat ovaries (highly enriched in primordial and small
primary follicles, targeted by VCD) has identified that follicle
loss is first seen on Day 6 of culture (d6) [25]. Oligoarray
analysis demonstrated that, following follicle loss, mRNA
encoding Kit was reduced in rat ovaries in response to VCD
exposure via in vivo dosing (d15) or in vitro culture (d8) [26].
A study to evaluate a role for PIK3 signaling (downstream
of KIT) in VCD-induced ovotoxicity used the PIK3 inhibitor,
LY294002 [25]. Inhibition of PIK3 signaling protected the
primordial follicle pool from VCD-induced follicle loss, but
did not prevent VCD-induced depletion of small primary
follicles. Therefore, it was hypothesized that VCD increases
recruitment of primordial follicles into the small primary pool
as a mode of ovotoxicity [25].
Due to the hypothesized role of the KIT signaling pathway
in VCD-induced ovotoxicity, it is of interest to characterize
cellular events initiated by VCD. Therefore, this study was
designed to investigate the earliest effects of VCD on
localization of KIT protein and its downstream PIK3 signaling
pathway members—AKT1 and FOXO3—in PND4 F344 rat
ovaries at time points prior to VCD-induced follicle loss.
MATERIALS AND METHODS
Reagents
VCD (mixture of isomers, .99% purity), 2-b-mercaptoethanol, 30%
acrylamide/0.8% bis-acrylamide, ammonium persulfate, glycerol, N0,N0,N0,N0-
tetramethyl-ethylenediamine (TEMED), Tris base, TrisHCL, sodium chloride,
Tween-20, bovine serum albumin (BSA), ascorbic acid (vitamin C), and
transferrin were purchased from Sigma-Aldrich Inc. (St Louis, MO). 2-(4-
Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002; CAS# 154447-
36-6) was purchased from A.G. Scientific, Inc. (San Diego, CA). Dulbecco
modified Eagle medium/nutrient mixture F-12 (Ham) 13 (DMEM/Ham F12),
Albumax, penicillin/streptomycin (5000 U/ml and 5000 lg/ml, respectively),
Hanks balanced salt solution (without CaCl
2
, MgCl
2
, or MgSO
4
), custom-
designed primers, and Superscript III One-Step RT-PCR System were obtained
from Invitrogen Co. (Carlsbad, CA). Millicell-CM filter inserts were purchased
from Millipore (Bedford, MA), and 48-well cell culture plates were obtained
from Corning, Inc. (Corning, NY). RNeasy Mini kit, QIAshredder kit, RNeasy
MinElute kit, and Quantitect SYBR Green PCR kit were purchased from
Qiagen Inc. (Valencia, CA). Anti-KIT antibody was purchased from DAKO
(Carpinteria, CA). Anti-AKT and anti-pAKT antibodies were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Anti-FOXO3 antibody was
purchased from Upstate Biotechnology (Lake Placid, NY), and anti-pFOXO3
antibody was purchased from Cell Signaling (Danvers, MA). Goat anti-rabbit
secondary antibody was purchased from Pierce Biotechnology (Rockford, IL).
Cy-5-streptavidin was obtained from Vector (Burlingame, CA). YOYO-1 was
purchased from Molecular Probes (Eugene, OR).
Animals
A breeding colony was established from Fischer 344 (F344) rats that were
originally purchased from Harlan Laboratories (Indianapolis, IN) to use as a
source of PND4 female rat pup ovaries for culture. All pregnant animals were
housed singly in plastic cages and maintained in a controlled environment (22
6 28C, 12L:12D). The animals were provided a standard diet with ad libidum
access to food and water and allowed to give birth. All animal experiments
were approved by the University of Arizona’s Institutional Animal Care and
Use Committee.
In Vitro Ovarian Culture
Ovaries from PND4 F344 rats were cultured as previously described [27].
Briefly, PND4 female F344 rats were euthanized by CO
2
inhalation followed
by decapitation. Each ovary was removed, trimmed of oviduct and excess
tissue, and placed on a piece of Millicell-CM membrane floating on 250 ll of
DMEM/Ham F12 medium containing 1 mg/ml BSA, 1 mg/ml Albumax, 50 lg/
ml ascorbic acid, 5 U/ml penicillin per 5 lg/ml streptomycin, and 27.5 lg/ml
transferrin per well in a 48-well plate previously equilibrated to 378C. Using
fine forceps, a drop of medium was placed to cover the top of the ovary to
prevent drying. Plates containing ovaries were cultured at 378C and 5% CO
2
in
air. For those cultures lasting more than 2 days, media were removed and fresh
media and treatment were replaced every 2 days. Ovaries in culture maintained
viability throughout the entire time course (previously up to 15 days [27]).
RNA Isolation
Following 2, 4, 6, or 8 days of in vitro culture, ovaries treated with vehicle
control or VCD (30 lM) were stored in RNAlater at 808C. Total RNA was
isolated (n¼ 3; 10 ovaries per pool) using an RNeasy Mini kit. Briefly, ovaries
were lysed and homogenized using a motor pestle followed by applying the
mixture onto a QIAshredder column. The QIAshredder column containing
ovarian tissue sample was centrifuged at 14 000 rpm for 2 min. The resulting
eluant was applied to an RNeasy mini column, allowing RNA to bind to the
filter cartridge. Following washing, RNA was eluted from the filter and
concentrated using an RNeasy MinElute kit. Briefly, isolated RNA was applied
to an RNeasy MinElute spin column, and after washing, RNA was eluted using
14 ll of RNase-free water. RNA concentration was determined using an ND-
1000 Spectrophotometer (k ¼ 260/280nm; NanoDrop technologies, Inc.,
Wilmington, DE).
First-Strand cDNA Synthesis and Real-Time Polymerase
Chain Reaction
Total RNA (0.5 lg) was reverse transcribed into cDNA using the
Superscript III One-Step RT-PCR System. Complementary DNA was diluted
(1:25) in RNase-free water. Two microliters of diluted cDNA were amplified
on a Rotor-Gene 3000 using Quantitect SYBR Green PCR kit and custom-
designed primers (Akt1 forward: 50-ACCTCTGAGACCGACACCAG-30, Akt1
reverse: 50-AGGAGAACTGGGGAAAGTGC-30; Foxo3 forward: 50-CAAC
CAAGGAAATGCTCCTC-30, Foxo3 reverse: 50-CTGTGGCCCTTATCCTT
GAA-30; Actb forward: 50-TCTATCCTGGCCTCACTGTC-30, Actb reverse:
50-ACGCAGCTCAGTAACAGTCC-30). The cycling program consisted of a
15-min hold at 958C and 45 cycles of denaturing at 958C for 15 sec, 45 cycles
of annealing at 588C for 15 sec, and 45 cycles of extension at 728C for 20 sec,
at which point data were acquired. Product melt conditions were determined
using a temperature gradient from 728C to 998C, with a 18C increase at each
step. There was no difference in b-actin (ACTB) mRNA between vehicle
control and VCD-treated ovaries. Therefore, each sample was normalized to
ACTB before quantification. For graphical purposes, only one control value is
presented; however, control reactions were performed at each time point, and
VCD-induced effects were expressed as a fold change relative to the control on
that day.
Protein Isolation
Pools of whole ovarian protein (10 ovaries per pool) homogenates were
prepared from cultured ovaries via homogenization in tissue lysis buffer as
previously described [28]. Briefly, homogenized samples were placed on ice for
30 min, followed by two rounds of centrifugation at 10 000 rpm for 15 min.
Supernatant was aliquoted and stored at 808C until further use. Protein was
quantified using a standard bicinchoninic acid protocol on a 96-well assay
plate. Emission absorbance values were detected with a k¼ 540 nm excitation
on a Synergy HT Multi-Detection Microplate Reader using KC4 software (Bio-
Tek Instruments, Inc., Winooski, VT). Protein concentrations were calculated
from a BSA protein standard curve.
Western Blot Analysis
SDS-PAGE (10%) was used to separate homogenate proteins (10 lg; n ¼
3), and these were subsequently transferred onto nitrocellulose membranes as
previously described [28]. Briefly, membranes were blocked for 1 h with
shaking at 48C in 5% milk in Tris-buffered saline (TBS) with Tween-20
(TTBS). Membranes were incubated with primary antibody in 5% milk in
TTBS overnight at 48C. Antibody dilutions were anti-KIT (1:400), anti-AKT
(1:50), anti-pAKT (1:200), anti-FOXO3 (1:500), anti-pFOXO3 (1:50), anti-
Actin (1:1000), and anti-PPIB (peptidylprolyl isomerase B [PPIB]/cyclophilin;
1:2000). Membranes were washed three times for 10 min each with TTBS.
Horseradish peroxidase-conjugated secondary antibody (1:2000 dilution) was
added for 1 h at room temperature. Membranes were washed three times for 10
min each in TTBS, followed by a single wash for 10 min in TBS. Western blots
744 KEATING ET AL.
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were detected by chemiluminescence (using electrochemiluminescence plus
chemiluminescence detection substrate) and exposed to x-ray film. Densitom-
etry of the appropriate bands was perfomed using Image J software (http://
rsbweb.nih.gov/ij/). Individual treatment values were normalized to one of two
loading controls, PPIB or ACTB.
Immunofluorescence Staining and Confocal Microscopy
Following in vitro culture for 2 or 4 days, ovaries treated with vehicle
control or VCD (30 lM) were fixed in 4% buffered formalin for 2 h, transferred
to 70% ethanol, embedded in paraffin, and serially sectioned, and every 10th
section was mounted. Sections were deparaffinized (approximately 10 sections
per ovary) and incubated with primary antibodies directed against KIT (1:400
dilution), pAKT (1:50 dilution), FOXO3 (1:100 dilution), or pFOXO3 (1:50
dilution) at 48C overnight. Specificity for these antibodies was determined after
observing a single protein band at the expected molecular weight by Western
blotting (data not shown). Blocking solution for immunofluorescence was 5%
BSA. Secondary biotinylated antibody was applied for 1 h, followed by CY-5-
streptavidin (1 h; 1:100 dilution). Sections were treated with RNase A (100 lg/
ml) for 1 h, followed by staining with YOYO-1 (10 min; 5 nM). Slides were
repeatedly rinsed with PBS, cover-slipped, and stored in the dark (48C) until
visualization. Primary antibody was not added to immunonegative ovarian
sections. Immunofluorescence was visualized on a Zeiss (LSM 510 NLO-Meta)
confocal microscope with an argon and helium-neon laser projected through the
tissue into a photomultiplier at k¼ 488 and 633 nm for YOYO-1 (green) and
CY-5 (red), respectively. All images were captured using a 403 objective lens.
Multiple readings were taken throughout the sections. Protein staining was
quantified using ImageJ software. Briefly, integrated density of protein staining
was measured in five primordial and five small primary follicles per section.
Average number of follicles analyzed per ovary was primordial, 139, and small
primary, 92.
Statistical Analysis
Comparisons were made between treatments using StatView 5 software
(SAS Institute Inc., Cary, NC) ANOVA and Fisher protected least-significant
difference multiple range test. Statistical analysis comparing protein immuno-
fluorescence staining in control or VCD-treated ovaries was carried out by
comparing integrated density measurements within each staining day (one
ovary per staining; n¼ 3). Statistical analysis was carried out on raw data for
each n, and for graphical purposes values were expressed as a percentage of the
control treatments (n¼ 3). The assigned level of significance for all tests was P
, 0.05, with P , 0.1 considered as a trend for a difference.
RESULTS
Effect of VCD Treatment on Akt1 and Foxo3 mRNA over
a Time Course of Exposure in PND4 F344 Rat Ovaries
Previous studies in cultured PND4 F344 rat ovaries
determined that follicle loss in response to VCD (30 lM) first
occurs on d6 [25]. It was previously reported that, under those
same conditions, mRNA encoding Kit was first reduced by
VCD on d4 of culture [26]. Thus, to further investigate a
temporal association with onset of follicle loss, PND4 F344 rat
ovaries were cultured with or without VCD (30 lM) for 2–8
days to measure changes in mRNA encoding Akt1 or Foxo3.
Relative to control-treated ovaries, Akt1 mRNA was reduced (P
, 0.05) on d4 of VCD treatment; however, there was no effect
on d6 or d8 (Fig. 1A). Foxo3 mRNA was unchanged on d2 and
d4 of VCD exposure, but was reduced on d6 (P , 0.05; Fig.
1B) and d8 (P , 0.1; Fig. 1B).
Effect of VCD Exposure on KIT, AKT, pAKT, FOXO3,
and pFOXO3 Proteins
The effect of VCD exposure on ovarian KIT, AKT, pAKT,
FOXO3, and pFOXO3 protein levels was evaluated by
Western blotting or immunoflourescence staining as analyzed
by confocal microscopy. The time points chosen for immuno-
fluorescence staining were d2 and d4 of VCD exposure, i.e.,
times preceding VCD-induced follicle loss (d6). PND4 F344
rat ovaries were cultured in control media with or without VCD
(30 lM) for 2–6 days. Relative to control, total ovarian KIT
protein was reduced (P , 0.05) on d4 but not on d2 of culture
(Fig. 2, A and B). Previously, it was shown by immuno-
flourescence staining that KIT protein is localized to the
pericytoplasmic region of the oocyte in PND4 ovaries cultured
for 8 days in control medium [26]. On d2 and d4 of culture,
KIT protein is also localized to the oocyte pericytoplasmic
region in both primordial and small primary follicles (Fig. 2,
C–G). As with Western blot analysis, there was no effect of
VCD on KIT protein staining on d2 in either primordial or
small primary follicles. However, by d4 of VCD exposure,
oocyte pericytoplasmic KIT protein staining was reduced (P ,
0.05) by 44% and 40% in primordial and small primary
follicles, respectively (Fig. 2H).
Total AKT staining was widely distributed throughout the
ovary (Fig. 3, A, B, E, and F). In contrast, pAKT staining is
primarily localized to the oocyte nucleus in primordial and
small primary follicles in cultured PND4 F344 rat ovaries (Fig.
3, C, D, G, and H). There was no effect of VCD on total AKT
protein (quantification not shown). Conversely, pAKT oocyte
nuclear staining was reduced (P , 0.05) on d2 (primordial,
39% below control; small primary follicles, 37% below
control; Fig. 3K) and d4 (P , 0.05, primordial, 27% below
control; P , 0.1, 29% small primary follicles, below control;
Fig. 3K) of VCD exposure. There was no effect of VCD on
pAKT staining in granulosa cells on d2 of exposure (Fig. 3L).
There was no effect of VCD on pAKT protein levels from
whole ovarian lysate as measured by Western blotting on d2–
d6 (Fig. 4, A and C). Additionally, no effect of VCD on total
FOXO3 protein was detected by Western blotting on d2–d6 of
VCD exposure (Fig. 4, B and C).
FIG. 1. Temporal effect of VCD exposure on Akt1 and Foxo3 mRNA
expression. Ovaries from PND4 F344 rats were cultured in vehicle control
media (CT) with or without 30 lM VCD for 2–8 days. Following
incubation, total RNA was isolated, reverse transcribed into cDNA, and
analyzed for Akt1 (A), Foxo3 (B), or Actb mRNA expression by RT-PCR as
described in methods. Values are mean fold level, relative to a day-
matched control 6 SEM; n¼ 3 (8–10 ovaries per pool). *P , 0.05; #P ,
0.1; different from control.
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The competitive inhibitor of PIK3, LY294002, was used to
confirm that AKT is a downstream phosphorylation target of
PIK3 in the oocyte. PND4 F344 ovaries were cultured for 2 or
4 days in control media with or without LY294002 (20 lM).
This concentration was previously determined using the in
vitro ovary culture method [25]. Immunofluorescence staining
demonstrated that, in the presence of PIK3 inhibition, pAKT
appeared to be enriched in the cytoplasm of primordial and
small primary follicle oocytes, relative to uninhibited PIK3.
Additionally, oocyte nuclear pAKT staining intensity was
markedly reduced with PIK3 inhibition (Fig. 5).
In primordial and small primary follicles, total FOXO3
protein stained the cytoplasm and nucleus of granulosa cells
and oocytes (Fig. 6, A, B, E, and F). Staining was
predominantly in the oocyte nucleus. There was no effect of
VCD exposure after 2 days on total oocyte FOXO3 protein
(cytoplasm and nucleus; Fig. 6K). By d4 of VCD exposure,
total FOXO3 protein staining in the oocyte was reduced (P ,
0.05) by 39% and 36% below control in primordial and small
primary follicles, respectively, as compared with control (Fig.
6K). Total FOXO3 protein was not quantified in granulosa
cells.
FIG. 2. Effect of VCD on KIT protein staining. PND4 F344 rat ovaries were cultured with vehicle control or 30 lM VCD for 2 or 4 days and processed for
Western blotting or immunoflourescence staining with confocal microscopy as described in Materials and Methods. A) Western blotting for KIT or ACTB
protein on d2 and d4 of VCD exposure (control ¼ c; VCD ¼ v). B) Quantification of KIT protein staining with normalization to ACTB. Representative
images for immunofluorescence staining of KIT protein on d4 are shown. Cy-5 red staining (anti-KIT antibody) for (C) control-treated ovary and (F) VCD-
treated ovary and genomic DNA (green YOYO1 stain) overlay for (D) control-treated ovary, (E) immunonegative control, and (G) VCD-treated ovary at 403
magnification. Thin arrows indicate primordial follicles; thick arrows indicate small primary follicles. Bar ¼ 20 lm. H) Quantification of oocyte
pericytoplasmic KIT protein staining on d2 and d4 of VCD exposure. Values are percentage of control; n¼3; *P , 0.05. By either method, oocyte plasma
membrane staining was reduced by VCD on d4 of incubation, relative to control.
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Unlike total FOXO3 protein, phosphorylated FOXO3
(pFOXO3) stained predominantly in the cytoplasm of gran-
ulosa cells in large primary and secondary follicles. There was
very little pFOXO3 staining in primordial and small primary
follicles. Additionally, no protein staining for pFOXO3 was
observed in the oocyte of any follicle size (Fig. 6, C, D, G, and
H).
DISCUSSION
It was previously determined that mRNA encoding Kit is
reduced from d4 onwards by VCD in cultured PND4 rat
ovaries [26]. The current study demonstrated that VCD also
decreases levels of KIT protein on the oocyte pericytoplasmic
membrane following d4 of exposure. Whether the d4 decrease
in protein resulted from reduced synthesis or from down-
FIG. 3. Effect of VCD on AKT and pAKT protein staining. PND4 F344 rat ovaries were cultured with vehicle control (A–D, I, and J) or 30 lM VCD
(E–H) for 2 or 4 days and processed for immunoflourescence staining with confocal microscopy as described in Materials and Methods.
Representative images for immunofluorescence staining for AKT (A, B, E, F, and I) or pAKT (C, D, G, H, and J) on d2 are shown. Cy-5 red staining
(anti-AKT antibody) for total AKT protein for (A) control-treated ovary and (E) VCD-treated ovary and genomic DNA (green YOYO1 stain) overlay for
(B) control-treated ovary, (F) VCD-treated ovary, and (I) immunonegative control at 403 magnification. Cy-5 red staining (anti-pAKT antibody) for
pAKT protein for (C) control-treated ovary and (G) VCD-treated ovary and genomic DNA (green YOYO1 stain) overlay for (D) control-treated ovary,
(H) VCD-treated ovary, and (J) immunonegative control at 403magnification. Thin arrows indicate primordial follicles; thick arrows indicate small
primary follicles. Bar¼ 20 lm. Quantification of (K) oocyte nuclear pAKT on d2 and d4 and (L) granulosa cell pAKT on d2 of VCD exposure. Values
are percentage of control; n ¼ 6; *P , 0.05; #P , 0.1. Phosphorylated AKT protein levels were reduced on d2 and d4 in the oocyte but not in
granulosa cells.
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regulation of KIT receptor cannot be determined at this time.
However, exogenous KITLG attenuated VCD-induced follicle
loss [26], supporting that VCD may interact with membrane-
bound KIT to disrupt its signaling pathway.
AKT is activated by phosphorylation downstream of PIK3
[29] and serves as an indirect measurement of PIK3 activity.
Genetic depletion of Akt1 in mice demonstrated a role for AKT
in regulating the primordial follicle pool [30]. Relative to wild
type, there was a reduction in numbers of growing early antral
and antral follicles in Akt1/ mouse ovaries on PND25. By
PND90, a reduction in primordial follicles was also observed.
Additionally, oocytes in Akt1/ primary follicles were larger
than those in Akt1þ/þ mice. This transient follicle phenotype
has also been seen in rat neonatal ovaries cultured with
exogenous KITLG [26] as well as ovaries from Foxo3/ mice
[9]. These collective observations suggest, therefore, that under
these conditions there has been selective activation/recruitment
of the oocyte and not of granulosa cells. Furthermore, these
findings are in support of a role for the oocyte in dictating
primordial follicle activation and recruitment.
In the current study, Western blot analysis showed that
VCD caused a decrease in total ovarian KIT protein on d4 of
culture. This was consistent with VCD-induced reduction in
KIT protein as visualized by immunoflourescence staining.
Conversely, no sustained effect of VCD on pAKT protein
levels in whole ovarian lysates was observed by Western blot
analysis. However, when visualized by immunofluorescent
staining there was a reduction in oocyte nuclear pAKT
following 2 days of VCD exposure. This event preceded the
VCD-induced reduction in KIT protein. Thus, the response of
KIT protein to VCD was consistent whether measured by
Western blot analysis or immunoflourescence staining. On the
other hand, there was a discrepancy between the two methods
when measuring pAKT protein. It is likely that because pAKT
was observed in granulosa cells as well as oocytes, and because
staining in granulosa cells was unaffected by VCD, a decrease
in oocyte-specific protein was not detectable by Western blot
analysis in whole ovarian protein fractions. This indicates the
benefit of using immunoflourescence staining to observe
selective ovarian compartmental distribution of various pro-
teins.
FIG. 4. Effect of VCD exposure on pAKT and FOXO3 protein from whole
ovarian lysate. Ovaries from PND4 F344 rats were cultured in vehicle
control media (CT) with or without 30 lM VCD for 2–6 days. Following
incubation, total protein from whole ovarian lysate was isolated and
Western blotting performed to detect pAKT and FOXO3 protein. A)
Quantification of pAKT protein staining with normalization to PPIB on d2–
6 of VCD exposure. B) Quantification of FOXO3 protein staining with
normalization to PPIB on d2–6 of VCD exposure. C) Representative
Western blot for pAKT, FOXO3, and PPIB after d2 of culture. Values are
percentage of control; n¼ 3 (control¼ c; VCD¼ v). There was no effect of
VCD exposure on pAKTor FOXO3 protein level from whole ovarian lysate.
FIG. 5. Effect of PIK3 inhibition on pAKT
protein staining. PND4 F344 rat ovaries
were cultured with vehicle control (A–C) or
LY294002 (20 lM; D and E) for 2 days and
processed for immunoflourescence staining
with confocal microscopy as described in
Materials and Methods. Representative im-
ages show Cy-5 red staining for pAKT
protein in (A) control-treated ovary and (D)
LY294002 treated ovary and genomic DNA
(green YOYO1 stain) overlay for (B) control-
treated ovary, (C) immunonegative control,
and (E) LY294002-treated ovary at 403
magnification. Thin arrows indicate pri-
mordial follicles; thick arrows indicate
small primary follicles. Bar ¼ 20 lm.
Overall staining for pAKT became less
intense in the cell nucleus and more
diffusely distributed in the cytoplasm.
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The observed decrease in oocyte nuclear pAKT protein
provides evidence of the earliest VCD-induced intracellular
event that has been seen to date and may be a downstream
response to VCD interaction with the KIT receptor. However,
it is possible that VCD interacts with oocyte cytoplasmic
proteins that themselves down-regulate PIK3 signaling inde-
pendent of KIT, and that the decrease in KIT protein is a
feedback response. Both of these scenarios are under
investigation. In any event, because decreased pAKT (d2) is
the earliest observed event caused by VCD, disruption of the
KIT-associated signaling pathway by VCD appears to be a key
critical event in VCD-induced follicle loss. Interestingly,
inhibition of PIK3 did not markedly affect phosphorylation
of AKT at Ser473; however, pAKT nuclear translocation was
affected, as demonstrated by the increase in cytoplasmic
localization of pAKT.
The effect of VCD on a substrate of pAKT, FOXO3, was
evaluated. VCD had no effect on Foxo3 mRNA expression
until such time as follicle loss was underway (d6 and d8). Also,
there was no effect of VCD on total FOXO3 protein when
FIG. 6. Effect of VCD on FOXO3 and pFOXO3 protein staining. PND4 F344 rat ovaries were cultured with vehicle control (A–D) or 30 lM VCD (E–H)
for 2 or 4 days and processed for immunoflourescence staining with confocal microscopy as described in Materials and Methods. Representative images
for immunofluorescence staining for FOXO3 (A, B, E, F, and I) and pFOXO3 (C, D, G, H, and J) on d4 are shown. Cy-5 red staining for total FOXO3
protein for (A) control-treated ovary and (E) VCD-treated ovary and genomic DNA (green YOYO1 stain) overlay for (B) control-treated ovary, (F) VCD-
treated ovary, and (I) immunonegative control at 403magnification. Cy-5 red staining for pFOXO3 protein for (C) control-treated ovary and (G) VCD-
treated ovary and genomic DNA (green YOYO1 stain) overlay for (D) control-treated ovary, (H) VCD-treated ovary, and (J) immunonegative control at 403
magnification. Thin arrows indicate primordial follicles; thick arrows indicate small primary follicles. Bar¼ 20 lm. K) Quantification of oocyte FOXO3
protein staining on d2 and d4 of VCD exposure. Values are percentage of control; n¼3; *P , 0.05. Oocyte FOXO3 protein levels were reduced on d4 of
VCD exposure. No pFOXO3 protein expression was detected in primordial or small primary follicle oocytes.
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measured by Western blotting in whole ovarian lysates. In
contrast, immunofluorescence staining revealed a decrease in
total FOXO3 protein within oocytes after d4 of VCD exposure.
As with pAKT, the inability of Western blot analysis to
demonstrate an oocyte-specific response measurable by
immunoflourescence staining for total FOXO3 protein is likely
due to the fact that overall ovarian distribution of the protein
was not affected by VCD.
The reduction in FOXO3 is likely a downstream event that
follows the VCD-induced reduction in phosphorylated AKT
signaling after 2 days of exposure. As seen in Foxo3/ mice
[9], the reduction in oocyte total FOXO3 protein caused by
VCD may result from uncoordinated recruitment of primordial
follicles into the small primary pool. Previously, it was
reported that FOXO3 becomes hyperphosphorylated and
undergoes nuclear export as a result of phosphorylation of
AKT [11]. In the current study, no staining for pFOXO3 was
seen in the oocyte of any follicle type. Instead, pFOXO3
protein staining was observed in the granulosa cells mainly in
large primary and secondary follicles, with staining in very few
primordial or small primary follicles. Thus, from these studies,
it is unlikely that the phosphorylation status of FOXO3 is
involved in VCD-induced ovotoxicity.
A number of studies using genetically deficient mice have
demonstrated the importance of KIT-initiated PIK3 signaling
for primordial follicle activation/recruitment and survival [6–
12]. In general, these studies have shown either accelerated
primordial follicle activation/recruitment or complete lack
thereof, depending upon which gene is affected. In either case,
the result is compromised ovarian function. Similar to Akt/
mice, it is possible that reduced pAKT caused by VCD is
associated with a compromised primordial follicle pool.
Additionally, the finely tuned balancing act that separates
primordial follicle viability from activation/recruitment as yet
remains poorly understood. If VCD causes an overall reduction
in PIK3 signaling, it would be expected that, in the face of
active or inhibited PIK3, VCD would have the same overall
effect on primordial and small primary follicle number as does
VCD alone. However, previous results indicated that when
recruitment via PIK3 signaling was inhibited, VCD could not
target primordial follicle numbers, supporting a role for
increased primordial follicle recruitment during VCD-induced
ovotoxicity. Surprisingly, no difference was observed in
protein signaling events between primordial and small primary
follicles, even though VCD exposure in the face of PIK3
inhibition resulted in different fates for these two follicle types.
Thus, whether VCD affects primordial follicle viability,
recruitment, or both remains to be determined.
The current study demonstrates that the initial ovotoxic
effects of VCD are not associated with changes in mRNA
encoding the Kit, Akt1, or Foxo3 genes. Rather, the earliest
events involve alterations in the subcellular distribution of KIT
(oocyte pericytoplasmic membrane), pAKT (oocyte nucleus),
and FOXO3 (oocyte nucleus þ cytoplasm) proteins. These
results, therefore, support a posttranslational protein signaling
pathway as the direct target of VCD, with decreases in
transcription of these genes as subsequent responses. The
changes seen in these signaling pathway members prior to
observed VCD-induced follicle loss also indicate that the
oocyte, not the granulosa cell, in primordial and primary
follicles is the direct target of VCD.
In summary, the collective findings support the hypothesis
that VCD interacts directly with membrane-bound KIT
receptor or its downstream signaling pathway in the oocyte
as an initial event in its mode of action. In addition to an
enhanced understanding of chemical-induced ovotoxicity,
these results support the use of VCD as an effective tool to
further identify mechanisms involved in primordial follicle
recruitment.
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